Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 1
1982 3
1983 4
1984 4
1985 4
1986 4
1987 6
1988 5
1989 5
1990 12
1991 8
1992 11
1993 12
1994 21
1995 27
1996 23
1997 26
1998 33
1999 43
2000 45
2001 52
2002 81
2003 103
2004 107
2005 104
2006 139
2007 173
2008 187
2009 217
2010 268
2011 320
2012 350
2013 403
2014 449
2015 520
2016 612
2017 648
2018 707
2019 798
2020 868
2021 954
2022 1201
2023 1201
2024 1338
2025 1678
2026 1255
2027 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,549 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean duan z[Author] (4,964 results)?
Zonated mechanosensing by PIEZO1 controls liver regeneration.
Zhang Y, Sun Y, Xu G, Wu Y, Shi Z, Chang Z, Liu J, Pang K, Liu S, Wang H, Rong W, Shao Z, Liu X, He Y, Yan Y, Zhou B, Yuan Z, Zhang XF, Offermanns S, Wang S. Zhang Y, et al. Among authors: yuan z. Science. 2026 Jul 2;393(6806):eaef0825. doi: 10.1126/science.aef0825. Epub 2026 Jul 2. Science. 2026. PMID: 42391361
Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.
Wu W, Yang Y, Chen H, Lu Y, Zeng Y, Zhao J, Du C, Lin Y, Peng P, Huang M, Zhang Y, Ouyang Q, Ding L, Cheng Z, Wen Y, Wu Z, Ye J, Ling L, Wang K, Lu Y, Zou G, Zhong J, Wang H, Lin D, Zeng D, Yao C, Chen Q, Zou L, Wang S, Yu Y, Yuan Z, Wang Y, Yao H. Wu W, et al. Among authors: yuan z. Signal Transduct Target Ther. 2026 May 22;11(1):191. doi: 10.1038/s41392-026-02720-6. Signal Transduct Target Ther. 2026. PMID: 42168151 Free PMC article. Clinical Trial.
Leriche Syndrome.
Yuan Z, Hu X, Cheng G. Yuan Z, et al. Radiol Cardiothorac Imaging. 2026 Aug;8(4):e250321. doi: 10.1148/ryct.250321. Radiol Cardiothorac Imaging. 2026. PMID: 42423465 No abstract available.
NicheTrans: spatial-aware cross-omics translation.
Wang Z, Zou Q, Lin S, Li S, Cui Y, Zhang D, Han C, Li Y, Li J, Zhao Y, Gao R, Song J, Yuan Z. Wang Z, et al. Among authors: yuan z. Nat Methods. 2026 Aug;23(8):1528-1539. doi: 10.1038/s41592-026-03153-3. Epub 2026 Jul 9. Nat Methods. 2026. PMID: 42426404
AAV gene therapy for homozygous familial hypercholesterolemia: a phase 1 trial.
Zheng T, Gao G, Xu C, Li R, Shao J, Wang X, Han X, Li J, Liu P, Xiong Y, Song L, Wang J, Wen S, Zhuo X, Wang G, Jiang L, Qu G, Chen T, She J, Luo Y, Yuan Z, Wu Y. Zheng T, et al. Among authors: yuan z. Nat Med. 2026 Jun;32(6):2137-2146. doi: 10.1038/s41591-026-04441-3. Epub 2026 Jun 4. Nat Med. 2026. PMID: 42243546 Clinical Trial.
Preclinical characterization and phase I results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors.
Ruan DY, Lin SY, Huang JJ, Li YH, Li N, Qu XJ, Du XB, Yin YM, Yuan ZY, Shi YX, Xu F, An X, Hong RX, Xia W, Xue C, Bi XW, Jiang KK, Zheng QF, Zhang YQ, Peng JJ, Liu ZY, Xiong HH, Suo AL, Lin RB, Zhang S, Tang SN, Yu Y, Li X, Wang X, Tian X, Lv P, Shen C, Lou LG, Wang L, Zhang ZP, Xu TJ, Chen TX, Wang SS, Xu RH. Ruan DY, et al. Among authors: yuan zy. Ann Oncol. 2026 Sep;37(9):1253-1265. doi: 10.1016/j.annonc.2026.05.003. Epub 2026 May 15. Ann Oncol. 2026. PMID: 42142622 Free article. Clinical Trial.
13,549 results
You have reached the last available page of results. Please see the User Guide for more information.